| |
IQVIA experts evaluate epidemiological variances for indication-specific distribution to better-inform diversity goals for clinical trials. Download the white paper.
|
|
| By Angus Liu It was only last spring that Biogen started layoffs that eventually shrank the company’s headcount by nearly 900 people last year. Now, a fresh round of job cuts targeting 1,000 positions has kicked off at the struggling drugmaker. At the same time, Biogen is spending $7.3 billion to buy rare disease specialist Reata Pharmaceuticals. |
|
|
|
By Max Bayer More than six months after Johnson & Johnson merged its infectious disease and vaccine units, the healthcare giant is cutting research and development for the unit altogether, according to sources familiar with the decision. |
By Angus Liu Novartis is cutting another 103 jobs at its U.S. headquarters in New Jersey, where the pharma giant just recently executed a 285-person round of layoffs. |
By Gabrielle Masson Layoffs in the biotech industry for 2023 have matched the total number of companies that cut staff in all of 2022, with 119 biopharmas reporting workforce reductions so far this year, according to an analysis of Fierce Biotech data. |
|
Wednesday, August 30, 2023 | 1pm ET/ 10am PT Enzymes have long demonstrated their utility as a green alternative to metal-based catalysts, but the evolution time required can be significant. Join this webinar to learn about an extracellular strategy that reduces the evolution cycle and enables biocatalysis to be used much earlier in development. Register now.
|
|
By Nick Paul Taylor An “inadvertent disclosure” has given the world a look at Roche’s eagerly anticipated TIGIT data. Having kept its cards close to its chest throughout the phase 3 lung cancer study, the Swiss drugmaker published interim overall survival results Wednesday after they were mistakenly made public. |
By Kevin Dunleavy Merck cancer superstar Keytruda is projected to be the world’s top selling drug by a huge margin in 2028, according to a report by Evaluate. On its list of top 10 drugs by sales in 2028, Keytruda is expected to top the $30 billion mark, with no other therapy predicted to reach $20 billion in sales. |
By Conor Hale First spun out of Stanford University in late 2019, the company's deep learning platform helps design small-molecule drug compounds and predicts how they interact with the body. |
By Angus Liu Novo Nordisk is struggling to meet strong demand for Wegovy, and the company has reportedly tapped another contract manufacturer to churn out the popular weight-loss drug. |
By Ben Adams Bayer has tapped the Harris Poll for a new survey on how Americans feel about finding out if they have cancer, and the results have revealed a worrying trend. |
By Helen Floersh Researchers have, for the first time, reconstructed a tune from a person’s brain activity as they listened to a song, a feat that marks a major milestone in scientists’ ability to decode and understand how the brain perceives music. It could eventually make assistive voice technologies and speech prosthetics better at replicating human speech by improving their prosody. |
Fierce podcastsDon’t miss an episode |
| | This week on "The Top Line," we discuss the trends seen at Cannes Lions, the top compensated CEOs in the industry, and the cancer drug shortage |
|
|---|
|
|
|
Tuesday, September 5th, 2023 | 10am ET / 7am PT Process chemistry plays a pivotal role in various stages of the pharmaceutical R&D cycle. However, support for preclinical and early clinical phases demands a delicate balancing act. Join usas we explore critical process chemistry issues that commonly arise to unlock the secrets for streamlining drug development and paving the way to successful IND submissions. Register now.
|
|
| WhitepaperUnravel the intricacies of Cell Line Development in biotherapeutics production with our latest eBook chapter. Sponsored By: Danaher Life Sciences |
| WhitepaperLearn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services |
| VideoLearn how to turn patient-focused innovations into life-changing treatments. Sponsored by: Cognizant |
| WhitepaperIn oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| ResearchLearn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| |
|
